The effect of radiofrequency electromagnetic fields (RF-EMF) on biomarkers of oxidative stress in vivo and in vitro: A protocol for a systematic review.

Electrophilic species Free radicals High frequency electromagnetic fields Oxidative stress ROS Radiofrequency electromagnetic fields SAR Systematic review W/kg

Journal

Environment international
ISSN: 1873-6750
Titre abrégé: Environ Int
Pays: Netherlands
ID NLM: 7807270

Informations de publication

Date de publication:
01 2022
Historique:
received: 07 04 2021
revised: 22 09 2021
accepted: 08 10 2021
pubmed: 19 10 2021
medline: 8 1 2022
entrez: 18 10 2021
Statut: ppublish

Résumé

Oxidative stress is conjectured to be related to many diseases. Furthermore, it is hypothesized that radiofrequency fields may induce oxidative stress in various cell types and thereby compromise human and animal health. This systematic review (SR) aims to summarize and evaluate the literature related to this hypothesis. The main objective of this SR is to evaluate the associations between the exposure to radiofrequency electromagnetic fields and oxidative stress in experimental models (in vivo and in vitro). The SR framework has been developed following the guidelines established in the WHO Handbook for Guideline Development and the Handbook for Conducting a Literature-Based Health Assessment). We will include controlled in vivo and in vitro laboratory studies that assess the effects of an exposure to RF-EMF on valid markers for oxidative stress compared to no or sham exposure. The protocol is registered in PROSPERO. We will search the following databases: PubMed, Embase, Web of Science Core Collection, Scopus, and the EMF-Portal. The reference lists of included studies and retrieved review articles will also be manually searched. Data will be extracted according to a pre-defined set of forms developed in the DistillerSR online software and synthesized in a meta-analysis when studies are judged sufficiently similar to be combined. If a meta-analysis is not possible, we will describe the effects of the exposure in a narrative way. The risk of bias will be assessed with the NTP/OHAT risk of bias rating tool for human and animal studies. We will use GRADE to assess the certainty of the conclusions (high, moderate, low, or inadequate) regarding the association between radiofrequency electromagnetic fields and oxidative stress. This work was funded by the World Health Organization (WHO). The protocol was registered on the PROSPERO webpage on July 8, 2021.

Sections du résumé

BACKGROUND
Oxidative stress is conjectured to be related to many diseases. Furthermore, it is hypothesized that radiofrequency fields may induce oxidative stress in various cell types and thereby compromise human and animal health. This systematic review (SR) aims to summarize and evaluate the literature related to this hypothesis.
OBJECTIVES
The main objective of this SR is to evaluate the associations between the exposure to radiofrequency electromagnetic fields and oxidative stress in experimental models (in vivo and in vitro).
METHODS
The SR framework has been developed following the guidelines established in the WHO Handbook for Guideline Development and the Handbook for Conducting a Literature-Based Health Assessment). We will include controlled in vivo and in vitro laboratory studies that assess the effects of an exposure to RF-EMF on valid markers for oxidative stress compared to no or sham exposure. The protocol is registered in PROSPERO. We will search the following databases: PubMed, Embase, Web of Science Core Collection, Scopus, and the EMF-Portal. The reference lists of included studies and retrieved review articles will also be manually searched.
STUDY APPRAISAL AND SYNTHESIS METHOD
Data will be extracted according to a pre-defined set of forms developed in the DistillerSR online software and synthesized in a meta-analysis when studies are judged sufficiently similar to be combined. If a meta-analysis is not possible, we will describe the effects of the exposure in a narrative way.
RISK OF BIAS
The risk of bias will be assessed with the NTP/OHAT risk of bias rating tool for human and animal studies. We will use GRADE to assess the certainty of the conclusions (high, moderate, low, or inadequate) regarding the association between radiofrequency electromagnetic fields and oxidative stress.
FUNDING
This work was funded by the World Health Organization (WHO).
REGISTRATION
The protocol was registered on the PROSPERO webpage on July 8, 2021.

Identifiants

pubmed: 34662800
pii: S0160-4120(21)00557-2
doi: 10.1016/j.envint.2021.106932
pmc: PMC8668870
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106932

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

Free Radic Biol Med. 2015 Jan;78:233-5
pubmed: 25462642
Environ Int. 2016 Jul-Aug;92-93:617-29
pubmed: 26857180
Environ Health Perspect. 2014 Jul;122(7):711-8
pubmed: 24755067
Free Radic Biol Med. 2015 Apr;81:100-6
pubmed: 25614459
Environ Int. 2021 Jan;146:106300
pubmed: 33395944
Free Radic Biol Med. 2005 Mar 15;38(6):698-710
pubmed: 15721980
Mol Aspects Med. 2016 Jun;49:1-7
pubmed: 27112802
Int J Hyg Environ Health. 2018 Apr;221(3):367-375
pubmed: 29402696
J Clin Epidemiol. 2011 Apr;64(4):383-94
pubmed: 21195583
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120
Environ Res. 2019 Sep;176:108517
pubmed: 31202043
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
Health Phys. 1998 Apr;74(4):494-522
pubmed: 9525427
Int J Mol Sci. 2021 Apr 06;22(7):
pubmed: 33917298
Evid Based Med. 2017 Jun;22(3):85-87
pubmed: 28320705
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Free Radic Biol Med. 2000 Mar 15;28(6):838-45
pubmed: 10802213
Bioelectromagnetics. 2015 Feb;36(2):133-48
pubmed: 25644546
J Nutr. 1972 May;102(5):689-96
pubmed: 5022203
Phys Med Biol. 2006 Oct 7;51(19):4951-65
pubmed: 16985280
Free Radic Biol Med. 2005 Mar 15;38(6):711-8
pubmed: 15721981
Reprod Biol Endocrinol. 2009 Oct 22;7:114
pubmed: 19849853
J Mol Cell Cardiol. 2014 Aug;73:2-9
pubmed: 24512843
Int J Mol Sci. 2018 Jul 19;19(7):
pubmed: 30029554
Biometrics. 2000 Jun;56(2):455-63
pubmed: 10877304
Health Phys. 2016 Dec;111(6):528-541
pubmed: 27798477
Redox Biol. 2016 Aug;8:205-15
pubmed: 26820564
Environ Health. 2011 Jan 25;10(1):10
pubmed: 21266038
Biochim Biophys Acta. 2013 May;1830(5):3139-42
pubmed: 23127894
Free Radic Biol Med. 2011 Nov 1;51(9):1636-42
pubmed: 21824516
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142
pubmed: 31643080
Am J Epidemiol. 2012 Jan 1;175(1):66-73
pubmed: 22135359
Free Radic Biol Med. 2013 Aug;61:408-15
pubmed: 23608465
Arch Toxicol. 2017 Jul;91(7):2551-2575
pubmed: 28501917
Health Phys. 2020 May;118(5):483-524
pubmed: 32167495
Antioxid Redox Signal. 2015 Nov 10;23(14):1144-70
pubmed: 26415143
J R Stat Soc Ser A Stat Soc. 2009 Jan;172(1):137-159
pubmed: 19381330
J Clin Epidemiol. 2009 Oct;62(10):e1-34
pubmed: 19631507
Redox Biol. 2017 Apr;11:613-619
pubmed: 28110218
Arq Bras Cir Dig. 2012 Jan-Mar;25(1):49-51
pubmed: 22569979
Antioxid Redox Signal. 2018 Mar 20;28(9):797-818
pubmed: 29084451
Chem Biol Interact. 1996 Sep 27;102(1):17-36
pubmed: 8827060
BMC Med Res Methodol. 2016 Aug 02;16:91
pubmed: 27485429

Auteurs

Bernd Henschenmacher (B)

Federal Office for Radiation Protection, Ingolstädter Landstraße 1, 85764 Oberschleißheim, Germany. Electronic address: bhenschenmacher@bfs.de.

Annette Bitsch (A)

Fraunhofer Institute for Toxicology and Experimental Medicine, Chemical Safety and Toxicology, Nikolai-Fuchs-Straße 1, 30625 Hannover, Germany. Electronic address: annette.bitsch@item.fraunhofer.de.

Tonia de Las Heras Gala (T)

Federal Office for Radiation Protection, Ingolstädter Landstraße 1, 85764 Oberschleißheim, Germany. Electronic address: theras@bfs.de.

Henry Jay Forman (HJ)

Leonard Davis School of Gerontology, University of Southern California, 3715 McClintock Avenue, Los Angeles, CA 90089, USA; University of California Merced, 5200 Lake Road, Merced, CA 95343, USA.

Athanassios Fragoulis (A)

Department of Anatomy and Cell Biology, Uniklinik RWTH Aachen, Wendlingweg 2, 52074 Aachen, Germany. Electronic address: afragoulis@ukaachen.de.

Pietro Ghezzi (P)

Brighton and Sussex Medical School, University of Sussex, Trafford Centre, Falmer BN1 9RY, United Kingdom; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy.

Rupert Kellner (R)

Fraunhofer Institute for Toxicology and Experimental Medicine, Chemical Safety and Toxicology, Nikolai-Fuchs-Straße 1, 30625 Hannover, Germany. Electronic address: rupert.kellner@item.fraunhofer.de.

Wolfgang Koch (W)

Fraunhofer Institute for Toxicology and Experimental Medicine, Chemical Safety and Toxicology, Nikolai-Fuchs-Straße 1, 30625 Hannover, Germany. Electronic address: wolfgang.koch@item.fraunhofer.de.

Jens Kuhne (J)

Federal Office for Radiation Protection, Ingolstädter Landstraße 1, 85764 Oberschleißheim, Germany. Electronic address: jkuhne@bfs.de.

Dmitrij Sachno (D)

Fraunhofer Institute for Toxicology and Experimental Medicine, Chemical Safety and Toxicology, Nikolai-Fuchs-Straße 1, 30625 Hannover, Germany. Electronic address: dmitrij.sachno@item.fraunhofer.de.

Gernot Schmid (G)

Seibersdorf Laboratories, Campus Seibersdorf, 2444 Seibersdorf, Austria. Electronic address: Gernot.Schmid@seibersdorf-laboratories.at.

Katya Tsaioun (K)

Evidence-based Toxicology Collaboration (EBTC), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. Electronic address: ktsaiou1@jhu.edu.

Jos Verbeek (J)

University Medical Center Amsterdam, Cochrane Work, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands. Electronic address: jverbeek@cochrane.org.

Robert Wright (R)

William H. Welch Medical Library, Johns Hopkins University School of Medicine, 2024 E. Monument Street, Suite 1-200, Baltimore, MD 21205, USA. Electronic address: rwrigh32@jhmi.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH